Delivery Order SPE2DB22D3301-SPE2DB25FY0NP
Award Date
2/25/25
Potential Completion Date
3/18/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PADCEV 30 MG VIALS to the Defense Logistics Agency (DLA). The award, valued at $27,719.00, was granted to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a period of performance through February 7, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $22,175.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with a completion date of February 25, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $25,863.30, is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,499.51, is for the supply of PADCEV 30 MG VIALS medical product. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen is the prime contractor, and the contract was not set aside for any specific business type. The contract is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with a ceiling value of $24,999.30 and a completion date of November 8, 2024. The contract type is Firm Fixed Price. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FL6K9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a ceiling value of $73,014.90 and a completion date of December 14, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award, valued at $116,823.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PADCEV 30 MG VIALS, and has an ultimate completion date of January 9, 2024. The contract is a firm fixed-price arrangement, and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG VIALS. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with a maximum value of $24,999.30 and a period of performance through August 20, 2024. This award is part of a larger IDC with DLA Troop Support Medical that has a potential value of up to $999,999,999 and is used to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a ceiling value of $11,087.60 and a completion date of February 27, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB24FEA02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price, is for the supply of PADCEV 30 MG VIALS, a medical product. The contract has an ultimate completion date of November 28, 2023 and a ceiling value of $19,470.64. This award is not designated as a set-aside contract....